Intellipharmaceutics International Inc. (NASDAQ:IPCIF) | WebDisclosure

Basculer en Français

8226	Companies
111047	Keywords
52767	Articles
60948	Press releases

Headlines Articles Press releases Intellipharmaceutics International Inc.

Home
Companies
Intellipharmaceutics International Inc.

BRIEF

published on 06/14/2024 at 22:41, 4 months 23 days ago

Intellipharmaceutics annonce un passage au marché OTC Expert

Commission Des Valeurs Mobilières De L'Ontario Intellipharmaceutique Interdiction D'opérations Sur Opérations Marché Des Experts OTC Formulaire 20-F
BRIEF

published on 06/14/2024 at 22:41, 4 months 23 days ago

Intellipharmaceutics Announces Downgrade to OTC Expert Market

Cease Trade Order Ontario Securities Commission Form 20-F Intellipharmaceutics OTC Expert Market
PRESS RELEASE

published on 06/14/2024 at 22:36, 4 months 23 days ago

Intellipharmaceutics Announces Downgrade to OTC Expert Market
Intellipharmaceutics International Inc. faces downgrade to OTC Expert Market due to filing default. Cease trade order from Ontario Securities Commission also in effect

Intellipharmaceutics International Inc. Pharmaceutical Company Cease Trade Order OTC Expert Market Filing Default
BRIEF

published on 03/13/2024 at 22:20, 7 months 25 days ago

Intellipharmaceutics International Inc. passe à NEX avec un nouveau régime d'options d'achat d'actions

Conformité Réglementaire NEX Intellipharmaceutique International Inc. Plan D'options D'achat D'actions Marché OTCQB
BRIEF

published on 03/13/2024 at 22:20, 7 months 25 days ago

Intellipharmaceutics International Inc. Moves to NEX with New Stock Option Plan

Intellipharmaceutics International Inc. Regulatory Compliance Stock Option Plan NEX OTCQB Marketplace
PRESS RELEASE

published on 03/13/2024 at 22:15, 7 months 25 days ago

Intellipharmaceutics International Inc. Announces Transfer of Listing to NEX and New Stock Option Plan
Intellipharmaceutics International Inc. announces listing transfer from TSX to NEX due to Cease Trade Order, new stock option plan approved. Company specializes in controlled-release drugs

Intellipharmaceutics International Inc. Cease Trade Order Stock Option Plan NEX Listing Transfer
BRIEF

published on 03/06/2024 at 20:50, 8 months 1 day ago

Intellipharmaceutics Faces Regulatory Challenges With Cease Trade Order

Regulatory Compliance Pharmaceuticals Cease Trade Order Intellipharmaceutics Investor Concerns
BRIEF

published on 03/06/2024 at 20:50, 8 months 1 day ago

Intellipharmaceutics fait face à des défis réglementaires avec une ordonnance d'interdiction d'opérations

Conformité Réglementaire Intellipharmaceutique Ordonnance D’interdiction D’opérations Médicaments Préoccupations Des Investisseurs
PRESS RELEASE

published on 03/06/2024 at 20:45, 8 months 1 day ago

Intellipharmaceutics Announces Cease Trade Order
Intellipharmaceutics International Inc. faces cease trade order for failure to file financial statements with Ontario Securities Commission. Company working on Required Filings

Financial Statements Intellipharmaceutics International Inc. Pharmaceutical Company Cease Trade Order OSC
PRESS RELEASE

published on 02/27/2024 at 01:38, 8 months 10 days ago

Intellipharmaceutics Announces Its Expected Delay in Filing Annual Audited Financial Statements and Annual Information Form
Intellipharmaceutics International Inc. announces delay in filing annual audited financial statements for the fiscal year ended November 30, 2023, due to applicable Canadian securities laws. Company working to expedite filing for compliance with OSC regulations

Intellipharmaceutics International Inc. Canadian Securities Laws Filing Delay Annual Audited Financial Statements OSC Regulations

Accesswire

Published on 11/08/2024 at 12:30, 37 minutes ago

Jaguar Mining Reports Financial Results for the Third Quarter 2024
Published on 11/08/2024 at 12:30, 37 minutes ago

Zomedica to Present at the Sidoti Micro Cap Conference November 14, 2024
Published on 11/08/2024 at 12:00, 1 hour 7 minutes ago

Fusion Energy Agreement Between RSE and BLUE LASER FUSION (USA)
Published on 11/08/2024 at 10:00, 3 hours 7 minutes ago

BluSky Carbon CEO Presents a Case for Climate Tech Optimism
Published on 11/08/2024 at 09:00, 4 hours 7 minutes ago

Greene Tweed Awarded 'Excellence in International Trade' at the 2024 East Midlands Chamber Business Awards

View all ACCESSWIRE

EQS Group

Published on 11/08/2024 at 12:31, 36 minutes ago

Original-Research: ORBIS SE (von GSC Research GmbH): Kaufen
Published on 11/08/2024 at 12:30, 37 minutes ago

Holding(s) in Company
Published on 11/08/2024 at 12:25, 42 minutes ago

freenet Executive Board formulates financial ambition until 2028 - EBITDA and free cash flow to grow significantly
Published on 11/08/2024 at 12:11, 56 minutes ago

PNE AG selected by the European Commission for funding a project to produce hydrogen
Published on 11/08/2024 at 12:01, 1 hour 6 minutes ago

EQS-Adhoc: Borussia Dortmund reports preliminary figures for the first quarter (Q1) of the 2024/2025 financial year

Les Echos

Published on 11/08/2024 at 12:32, 35 minutes ago

Louis Hachette Group announces the publication of its Information Document for listing on Euronext Growth (Paris)
Published on 11/08/2024 at 12:32, 35 minutes ago

Louis Hachette Group annonce la publication de son Document d’Information en vue de sa cotation sur Euronext Growth (Paris)
Published on 11/08/2024 at 12:15, 52 minutes ago

Louis Hachette Group announces the publication of its Information Document for listing on Euronext Growth (Paris)
Published on 11/08/2024 at 12:15, 52 minutes ago

Louis Hachette Group annonce la publication de son Document d’Information en vue de sa cotation sur Euronext Growth (Paris)
Published on 11/08/2024 at 08:00, 5 hours 7 minutes ago

DAMARTEX / Droits de vote bruts et réels 31 octobre 2024

View all LES ECHOS COMFI WIRE